Hyperaldosteronism: Clinical Trials

199 trials for Hyperaldosteronism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

71 completed, 50 recruiting, 46 unknown, 15 not yet recruiting. 54 Not applicable, 17 Phase 2, 16 Phase 4, 5 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable54Completed 18, Recruiting 16, Unknown 10, Not yet recruiting 5, Active not recruiting 3, Enrolling by invitation 1, Withdrawn 1
Phase 217Completed 8, Not yet recruiting 4, Recruiting 3, Active not recruiting 1, Unknown 1
Phase 416Completed 6, Unknown 5, Not yet recruiting 2, Recruiting 2, Enrolling by invitation 1
Phase 35Completed 3, Active not recruiting 1, Unknown 1
Phase 13Recruiting 2, Unknown 1
Early Phase 11Completed 1

Follow Hyperaldosteronism: new trials by email Literature Review of Hyperaldosteronism trials Research Report on Hyperaldosteronism

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy
Spironolactone (drug), Candesartan 8mg, Hydrochlorothiazide (HCTZ) 25 milligrams. - Hypertension
Phase 4Not yet recruitingOttawa Hospital Research Institute302027-01-012026-10-14
Comparing Inclisiran Versus Statin for Primary Aldosteronism
inclisiran, Lipophilic statins (such as Simvastatin, Atorvastatin, Fluvastatin, Lovastatin,Pitavastatin), Spironolactone (drug) - Primary Aldosteronism
Not applicableRecruitingThird Military Medical University502026-11-152026-11-12
SYH2072 Tablets in Participants With Primary Aldosteronism
SYH2072 tablets, Placebo - Primary Aldosteronism
Phase 2Not yet recruitingInnovStone Therapeutics Limited602026-11-132026-11-06
[11C]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept Study
[11C] Metomidate PETCT, Adrenal Venous Sampling - Primary Aldosteronism
Not applicableRecruitingChinese University of Hong Kong322026-11-012026-10-26
Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism
sauna session - Primary Aldosteronism, Hypertension
Not applicableNot yet recruitingUniversity of Calgary102026-09-302026-08-31
Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism
baxdrostat - Primary Aldosteronism
Not applicableNot yet recruitingQueen Mary University of London302026-09-152026-09-02
Kidney Stiffness Measured by Ultrasound in Patients With High Blood Pressure and Healthy Volunteers
Arterial Hypertension, Chronic Kidney Disease, Primary Aldosteronism
RecruitingAzienda Ospedaliera di Padova2402026-08-112026-11-03
Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma
Endoscopic Ultrasound-Guided Ethanol Ablation - Primary Aldosteronism, Aldosterone-Producing Adenoma
Not applicableNot yet recruitingChongqing Medical University302026-07-152026-07-14
Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)
Cushing s Syndrome, Cushing Disease
RecruitingAzienda Ospedaliero-Universitaria di Modena20002026-07-092026-11-09
Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism
Intensive BP control, Standard BP control - Primary Aldosteronism
Not applicableRecruitingChongqing Medical University38302026-07-072026-09-21
EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders
Sequential Dietary Sodium Modulation - Endocrine Disorders, Hypertension
Not applicableActive not recruitingFelix Beuschlein1002026-07-032026-07-27
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary Aldosteronism
SAL0140 Tablets, SAL0140 placebo - Primary Aldosteronism
Phase 2Not yet recruitingShenzhen Salubris Pharmaceuticals Co., Ltd.502026-06-122026-06-12
Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension
RFA -radiofrequency ablation, Adrenalectomy - Primary Aldosteronism Due to Conn Adenoma, Radiofrequency Ablation Treatment
Not applicableRecruitingUniversity Hospital, Toulouse1342026-06-052026-06-11
Study of QLS1410 in the Treatment of Primary Aldosteronism.
QLS1410, Placebo - Primary Aldosteronism
Phase 2Not yet recruitingQilu Pharmaceutical Co., Ltd.602026-06-012026-04-24
A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism
HRS-1780 Tablets, Placebo - Primary Aldosteronism
Phase 2Active not recruitingShandong Suncadia Medicine Co., Ltd.612026-04-232026-10-13
Effects of Glucocorticoid Therapy on Renal Function in Patients With PA Complicated by CKD After Adrenalectomy: A Multicenter RCT
Intervention_1 - Primary Aldosteronism Due to Adrenal Hyperplasia
Phase 4Not yet recruitingRuijin Hospital902026-04-222026-04-30
Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism
Finerenone - Primary Aldosteronism, Endocrine Hypertension
Not applicableRecruitingBangladesh Medical University1042026-04-152026-07-07
Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism
Saline Infusion Test - Primary Aldosteronism
RecruitingSeoul National University Hospital1502026-04-012026-06-02
Virtual Twins as Tools for Personalized Clinical Care in Renal Denervation - Pilot Study
Data collection in order to train the digital twin - Hypertension
Not yet recruitingAssistance Publique - Hôpitaux de Paris602026-04-012026-03-10
Prognosis of Primary Aldosteronism: A Prospective Cohort Study
Primary Aldosteronism
RecruitingXinjiang Medical University50002026-01-302026-02-03

Showing 20 of 199. Sign in to see all of them.

Narrower conditions

Hypertension (53)  ·  Adrenocortical Adenoma (14)  ·  Cushing Syndrome (14)  ·  Pheochromocytoma (11)  ·  ACTH Syndrome, Ectopic (8)  ·  Adrenal Insufficiency (7)  ·  Essential Hypertension (7)  ·  Hypokalemia (7)  ·  Adrenal Gland Neoplasms (6)  ·  Disease (6)  ·  Atrial Fibrillation (5)  ·  Adrenal incidentaloma (4)  ·  Arrhythmias, Cardiac (4)  ·  Bartter Syndrome (4)

Broader conditions

Adrenocortical Hyperfunction (198)  ·  Adrenal Gland Diseases (196)  ·  Endocrine System Diseases (196)  ·  Cardiovascular Diseases (63)  ·  Vascular Diseases (60)  ·  Neoplasms (37)  ·  Neoplasms by Site (29)  ·  Pathological Conditions, Signs and Symptoms (27)  ·  Endocrine Gland Neoplasms (26)  ·  Pathologic Processes (24)  ·  Adrenal Cortex Diseases (19)  ·  Adrenal Cortex Neoplasms (17)  ·  Adrenal Gland Neoplasms (17)  ·  Urogenital Diseases (17)  ·  Neoplasms by Histologic Type (16)

Interventions

Spironolactone (16)  ·  Adrenalectomy (8)  ·  Eplerenone (8)  ·  Amlodipine (6)  ·  Mineralocorticoid Receptor Antagonists (6)  ·  finerenone (6)  ·  Dexamethasone (4)  ·  Nifedipine (4)  ·  Hydrochlorothiazide (3)  ·  Pharmaceutical Preparations (3)  ·  Aminocaproic Acid (2)  ·  Blood Specimen Collection (2)  ·  Bosentan (2)  ·  Cefepime (2)  ·  Fosfomycin (2)

Sponsors

Chongqing Medical University (13)  ·  Third Military Medical University (10)  ·  Qifu Li (8)  ·  Changi General Hospital (6)  ·  National Taiwan University Hospital (6)  ·  University Hospital Padova (6)  ·  Brigham and Women's Hospital (5)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (5)  ·  Haukeland University Hospital (5)  ·  Peking Union Medical College Hospital (5)  ·  Queen Mary University of London (5)  ·  Seoul National University Hospital (5)  ·  Radboud University Medical Center (4)  ·  Xinjiang Medical University (4)  ·  Assistance Publique - Hôpitaux de Paris (3)

Countries

China (73)  ·  United States (20)  ·  United Kingdom (17)  ·  France (14)  ·  Italy (12)  ·  Canada (10)  ·  Netherlands (8)  ·  Singapore (8)  ·  Taiwan (7)  ·  Germany (6)  ·  Norway (5)  ·  South Korea (5)  ·  Sweden (4)  ·  Australia (3)  ·  Finland (3)

Top investigators

Xiongjing Jiang, MD (3)  ·  Gian Paolo Rossi, MD (2)  ·  Hui Dong, MD (2)  ·  Kwan-Dun Wu, MD, PhD (2)  ·  Ping Li (2)  ·  Qifu Li (2)  ·  Qifu Li, PhD (2)  ·  Shumin Yang (2)  ·  Shumin Yang, MD, PhD (2)  ·  Vin-Cent Wu, MD (2)  ·  Xiang Xie, PhD (2)  ·  Zhiming Zhu, MD (2)  ·  A.H. van den Meiracker, MD, PhD (1)  ·  Alexander Leung, Asst. Prof (1)

Results publications

PMID 26934393, PMID 32327102, PMID 17161262, PMID 15657580, PMID 28385310, PMID 28576687, PMID 29279316, PMID 35218017, PMID 36795418, PMID 21828936, PMID 29987110, PMID 32206838, PMID 32890265, PMID 35418526, PMID 16508586, PMID 16670162, PMID 18539224, PMID 19349554, PMID 21270113, PMID 22146510, PMID 22743644, PMID 25002246, PMID 27315757, PMID 27325147, PMID 29129575, PMID 30255616, PMID 30590677, PMID 31476901, PMID 31536622, PMID 33196558, PMID 33447758, PMID 33605538, PMID 33796078, PMID 34398686, PMID 36974473, PMID 37870836, PMID 10641708, PMID 11074243, PMID 12468575, PMID 12517689, PMID 12676966, PMID 12756408, PMID 15001583, PMID 15356010, PMID 15480108, PMID 15591226, PMID 15681560, PMID 15808809, PMID 15808810, PMID 15947891

NIH funding

2023 (2), 2018 (1), 2025 (1), R01DK096994 (1), R01HL075614 (1), R01HL153004 (1)